Considering that Merlin inhibits putative tumor-promoting functions of CD44 (as discussed in the introduction), we expected that deletion of Nf2 would lead to more a severe phenotype in Cd44-positive mice when compared to Cd44-negative equivalents. The gene discussed is CD44; the disease is neoplasm.